With both CMS and then perhaps the FDA getting in the way of commercial uptake of cxbladder, Pacific Edgecmight not be too happy with this study just released:
https://www.sciencedirect.com/scienc...89537024001457
We know that Cytology and cystoscopy remain the gold standard in diagnosis of bladder cancer. Cytology is highly specific but lacks sensitivity, and hence the development of tumour markers such as cxbladder.
Well these clever fellows have used Ai to improve analysis of cytology and the results after a four year large cohort study suggest significant improvement in sensitivity, above that of Fish and Cxbladder.
As with all these things, further studies are needed but I am really starting to think that we have missed the boat here